Cansortium Inc. (OTCMKTS:CNTMF – Get Rating) was the target of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 102,700 shares, a drop of 25.4% from the October 15th total of 137,700 shares. Based on an average daily trading volume, of 358,100 shares, the short-interest ratio is presently 0.3 days.
Analyst Upgrades and Downgrades
Separately, BTIG Research started coverage on shares of Cansortium in a research report on Friday, October 28th. They set a "buy" rating on the stock.
Get Cansortium alerts:Cansortium Stock Performance
Shares of OTCMKTS CNTMF opened at $0.16 on Friday. Cansortium has a 52-week low of $0.13 and a 52-week high of $0.78. The company's 50 day moving average price is $0.18 and its 200-day moving average price is $0.18.
About Cansortium
(Get Rating)
Cansortium Inc, through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles.
Further Reading
- Get a free copy of the StockNews.com research report on Cansortium (CNTMF)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.